(Q46015387)

English

Thalidomide resistance is based on the capacity of the glutathione-dependent antioxidant defense.

scientific article published in November 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

title

Thalidomide resistance is based on the capacity of the glutathione-dependent antioxidant defense (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

3

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

Jürgen Knobloch

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

author name string

Kerstin Reimann

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

Ulrich Rüther

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

language of work or name

English

0 references

publication date

1 November 2008

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

published in

Molecular Pharmaceutics

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

volume

5

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

page(s)

1138-1144

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 January 2020

issue

6

1 reference

stated in

Europe PubMed Central

PubMed ID

19434859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19434859%20AND%20SRC:MED&resulttype=core&format=json

(Q46015387)

Thalidomide resistance is based on the capacity of the glutathione-dependent antioxidant defense.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)